THE DEAL, AT A GLANCE
From the announcementQureight
01What it doesQureight is an end-to-end imaging company.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02Who is involvedBacked by Molten VenturesFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03What happenedQureight raised $20M Series B, announced 2026-07-28From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗04Why it mattersQureight’s $20m Series B supports scaling its end-to-end AI imaging technology for clinical trials as the lung and heart clinical trials market is expected to grow.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Qureight · Financing Record
Explore source-linked visual explanations for Qureight. Unsupported claims are withheld while source review continues.
Record 9199 · Recorded date: 2026-07-28
What it does
Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.
Explore company records →